Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastases to the Lung”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT06982222
What this trial is testing

Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Non-Small Cell Carcinoma+4 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT02726568
What this trial is testing

High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases

Who this might be right for
Non-small Cell Lung CancerBrain Metastases
Betta Pharmaceuticals Co., Ltd. 30
Early research (Phase 1)Study completedNCT00264420
What this trial is testing

Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation

Who this might be right for
Bone MetastasesBreast CancerLung Cancer+1 more
The Cleveland Clinic 4
Large-scale testing (Phase 3)Study completedNCT03653546
What this trial is testing

First Line Treatment in EGFR Mutation Positive Advanced NSCLC Patients With Central Nervous System (CNS) Metastases

Who this might be right for
Non-small Cell Lung CancerEGFR Gene MutationBrain Metastases
Alpha Biopharma (Jiangsu) Co., Ltd. 492
Early research (Phase 1)Study completedNCT02900664
What this trial is testing

PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)

Who this might be right for
Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma
Novartis Pharmaceuticals 283
Not applicableStudy completedNCT03413956
What this trial is testing

An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Jiangsu Cancer Institute & Hospital 10,885
Early research (Phase 1)Study completedNCT02658214
What this trial is testing

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

Who this might be right for
Small Cell Lung CarcinomaCarcinoma, Squamous Cell of Head and NeckStomach Neoplasms+7 more
AstraZeneca 32
Not applicableUnknownNCT04735588
What this trial is testing

Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP

Who this might be right for
Immune ThrombocytopeniaITPCovid19+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 140
Large-scale testing (Phase 3)Study completedNCT00172042
What this trial is testing

Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small-Cell Lung Cancer
Novartis Pharmaceuticals 437
Testing effectiveness (Phase 2)UnknownNCT06334757
What this trial is testing

Serplulimab Plus Bevacizumab and Chemotherapy for EGFR-mutant Metastatic NSCLC Patients After EGFR-TKI Treatment Failure

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Henan Cancer Hospital 46
Large-scale testing (Phase 3)Looking for participantsNCT07222566
What this trial is testing

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung CancerNon-Small Cell Lung CancerCarcinoma, Non-Small-Cell Lung+3 more
Pfizer 1,410
Not applicableUnknownNCT05050994
What this trial is testing

Ultrasound Guided Microwave Ablation of Splenomegaly in Children

Who this might be right for
Splenomegaly; Congestive, ChronicPanhematopenia; SplenicPortal Hypertension
Karolinska Institutet 10
Not applicableStudy completedNCT03006224
What this trial is testing

The Effects of Secondary Smoking During One Lung Ventilation

Who this might be right for
SmokingOxygen Deficiencies
Inonu University 60
Not applicableStudy completedNCT04396600
What this trial is testing

The Professional Peer Resilience Initiative

Who this might be right for
StressStress DisorderStress, Psychological+11 more
University of Minnesota 87
Not applicableLooking for participantsNCT06546007
What this trial is testing

Rarecells Molecular Biomarkers for Early Detection of Lung Cancer

Who this might be right for
Lung CancerPulmonary Neoplasm
Rarecells Diagnostics SAS 50
Early research (Phase 1)Study completedNCT02743637
What this trial is testing

A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors

Who this might be right for
Advanced MalignancyAdvanced Solid TumorsNeoplasm+1 more
SynDevRx, Inc. 32
Testing effectiveness (Phase 2)Looking for participantsNCT06362369
What this trial is testing

Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Who this might be right for
Advanced CancerAdvanced Solid TumorMelanoma+15 more
7 Hills Pharma, LLC 126
Not applicableEnded earlyNCT00970645
What this trial is testing

Study Comparing EBUS & EUS to Mediastinoscopy in Staging and Detection of Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Mayo Clinic 2
Testing effectiveness (Phase 2)Ended earlyNCT02521051
What this trial is testing

Phase I/II Trial of Alectinib and Bevacizumab in Patients With Advanced, Anaplastic Lymphoma Kinase (ALK)-Positive, Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Massachusetts General Hospital 11
Testing effectiveness (Phase 2)Study completedNCT04323527
What this trial is testing

Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2

Who this might be right for
SARS-CoV InfectionSevere Acute Respiratory Syndrome (SARS) Pneumonia
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado 278
Next Page